Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea

Scandinavian Journal of Gastroenterology
Hyungil SeoSang Hyoung Park

Abstract

Large-scale studies regarding the long-term efficacy of infliximab (IFX) treatment in non-Caucasian patients with ulcerative colitis (UC) are lacking. We analyzed the long-term outcomes of IFX in 195 Korean UC patients who received scheduled IFX treatments at Asan Medical Center. IFX failure was defined as IFX discontinuation due to colectomy or non-response to IFX, and additionally UC-related hospitalization or a need for rescue corticosteroids during the course of IFX. Between December 2006 and October 2016, a total of 3101 infusions of IFX were administered to 195 patients over a median period of 21 months. At the end of the follow-up, 86 patients (44.1%) were still receiving IFX without failure. IFX was stopped in 73 (37.4%) patients due to colectomy (23 patients, 11.8%), non-response to IFX (35 patients, 17.9%) or other reasons such as adverse events or patients' preferences (15 patients, 7.7%). An additional 36 (18.5%) patients experienced IFX failure during follow-up due to a need for rescue corticosteroids (13 patients, 6.7%), UC-related hospitalization (8 patients, 4.1%), or both (15 patients, 7.7%). The survival free of IFX failure was 58.1% at 1 year, 50.7% at 3 years and 44.8% at 5 years. In a multivariate regressio...Continue Reading

References

Nov 1, 1992·Scandinavian Journal of Gastroenterology·C Tysk, G Järnerot
Dec 24, 1987·The New England Journal of Medicine·K W SchroederD M Ilstrup
Nov 4, 2000·Journal of Gastroenterology and Hepatology·S K YangY K Kim
Dec 13, 2005·The New England Journal of Medicine·Paul RutgeertsJean Frédéric Colombel
Jan 9, 2007·Inflammatory Bowel Diseases·Sang Hyoung ParkJin-Ho Kim
Apr 19, 2007·Alimentary Pharmacology & Therapeutics·S L JakobovitsS P L Travis
Dec 19, 2008·Digestive Diseases and Sciences·Maha M Maher, Mahmoud I Nassar
May 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eun-Young JangSung-Han Kim
Jul 15, 2009·Gastroenterology·William J SandbornJean Frédéric Colombel
Mar 17, 2010·Inflammatory Bowel Diseases·Garrett Lawlor, Alan C Moss
Aug 26, 2010·The American Journal of Gastroenterology·Abderrahim OussalahLaurent Peyrin-Biroulet
Sep 1, 2008·Journal of Crohn's & Colitis·Marc FerrantePaul Rutgeerts
May 10, 2011·Journal of Clinical Gastroenterology·You Sun KimUNKNOWN IBD Study Group of the Korean Association for the Study of Intestinal Diseases
Nov 24, 2011·The American Journal of Gastroenterology·Alain BittonUNKNOWN Canadian Association of Gastroenterology Severe Ulcerative Colitis Consensus Group
Aug 24, 2012·Lancet·Ingrid OrdásWilliam J Sandborn
Jul 9, 2013·Journal of Gastroenterology and Hepatology·Kang-Moon LeeUNKNOWN IBD study Group of Korean Association for the Study of Intestinal Diseases
Mar 13, 2014·Journal of Crohn's & Colitis·J F RahierUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Aug 15, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Maria Theresa AriasMarc Ferrante
Oct 29, 2014·Intestinal research·Hyun Il SeoJeong Eun Shin
Feb 17, 2015·Alimentary Pharmacology & Therapeutics·K SagerC S Probert
Jun 23, 2015·Inflammatory Bowel Diseases·Sanjay K MurthyA Hillary Steinhart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.